awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q58765953-476423B1-5D85-4617-ADA2-6F07D58379F2
Q58765953-476423B1-5D85-4617-ADA2-6F07D58379F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58765953-476423B1-5D85-4617-ADA2-6F07D58379F2
Bevacizumab with Single-agent Chemotherapy in Previously Treated Non-squamous Non-small-cell Lung Cancer: Phase II Study
P2860
Q58765953-476423B1-5D85-4617-ADA2-6F07D58379F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58765953-476423B1-5D85-4617-ADA2-6F07D58379F2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d59977315ef328b218b1c3a2e3202dc9b2c7bf7c
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.